CMP
Coston McIsaac & Partners’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94K | Buy |
509
+1
| +0.2% | +$185 | 0.02% | 222 |
|
|
2025
Q1 | $106K | Buy |
508
+1
| +0.2% | +$209 | 0.03% | 185 |
|
|
2024
Q4 | $90K | Hold |
507
| – | – | 0.03% | 202 |
|
|
2024
Q3 | $100 | Buy |
507
+1
| +0.2% | – | 0.03% | 185 |
|
|
2024
Q2 | $86K | Buy |
506
+1
| +0.2% | +$170 | 0.03% | 192 |
|
|
2024
Q1 | $92K | Hold |
505
| – | – | 0.03% | 186 |
|
|
2023
Q4 | $78K | Buy |
505
+1
| +0.2% | +$154 | 0.03% | 202 |
|
|
2023
Q3 | $75K | Buy |
504
+1
| +0.2% | +$149 | 0.03% | 196 |
|
|
2023
Q2 | $67K | Hold |
503
| – | – | 0.02% | 221 |
|
|
2023
Q1 | $80K | Sell |
503
-15
| -3% | -$2.39K | 0.03% | 195 |
|
|
2022
Q4 | $83 | Buy |
518
+2
| +0.4% | – | 0.03% | 190 |
|
|
2022
Q3 | $69K | Buy |
516
+2
| +0.4% | +$267 | 0.03% | 177 |
|
|
2022
Q2 | $79K | Buy |
+514
| New | +$79K | 0.05% | 106 |
|